Related Experiment Video

Updated: Dec 25, 2025

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.8K

Pediatric Liver Transplantation: Then and Now

Lieu T Tran1, Philip C Carullo1, Diem Phuc T Banh1

  • 1Department of Pediatric Anesthesiology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.

Journal of Cardiothoracic and Vascular Anesthesia
|April 4, 2020
PubMed

Insights

This review examines 50 years of pediatric liver transplantation, covering patient data, surgical methods, and outcomes. Advances in immunosuppression and perioperative care have significantly improved results for children receiving liver transplants.

Area of Science:

  • Hepatology
  • Pediatric Surgery
  • Transplantation Medicine

Background:

  • Liver transplantation is a critical treatment for end-stage liver disease in children.
  • Significant advancements have occurred over the last five decades.

Purpose of the Study:

  • To provide a comprehensive review of pediatric liver transplantation over the past 50 years.
  • To analyze key aspects including demographics, management, surgical techniques, immunosuppression, and outcomes.

Main Methods:

  • Literature review of studies published over the last 50 years.
  • Analysis of patient demographics, perioperative management strategies, surgical innovations, immunosuppressive protocols, and patient outcomes.

Main Results:

  • Identification of trends in patient populations and disease etiologies.
  • Evaluation of the evolution of surgical techniques and their impact on success rates.
  • Assessment of changes in immunosuppression and their effect on graft survival and complications.

Conclusions:

  • Pediatric liver transplantation has evolved significantly, with improved outcomes.
  • Multidisciplinary care, surgical advancements, and optimized immunosuppression are crucial for successful pediatric liver transplantation.

Keywords:
graftinghepatic transplantationimmunosuppressantsliverliver transplantationoutcomes assessment

More Related Videos

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models09:23

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Published on: September 22, 2023

3.5K
Re-Arterialized Rat Partial Liver Transplantation with an in vivo Vessel-Oriented 70% Hepatectomy14:52

Re-Arterialized Rat Partial Liver Transplantation with an in vivo Vessel-Oriented 70% Hepatectomy

Published on: April 8, 2018

12.1K

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
259
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
223
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
134